Proarc | Lasting BPH Relief

Innovating prostate care for lasting relief

Benign Prostatic Hyperplasia (BPH) treatment made simple and effective

BPH is Widespread - and Underserved

Of men over 50

Of men over 80

M+

Patients in the U.S

The current dilemma

Damage to prostate tissue Lasting relief but Higher risk

Mechanical prostate retraction
Minimal risk but Short-term relief

ProArc resolves the dilemma with a new class in minimally invasive BPH Treatment

ProArc introduces Omega™: a dual therapy self-embedding implant designed to deliver durable symptom relief while preserving native prostate tissue.

Simple procedure

Low-risk

Lasting relief

Fully reversible

Eliminating the compromise in BPH treatment

Omega is a Minimally Invasive Treatment (MIST) that uses a self-embedding mechanical implant, securely anchored within tissue to minimize urine exposure and reduce the risk of migration or encrustation. The permanent implant gently retracts the prostate lobes, restoring natural urine flow.

Dual therapy

Integrates the advantages of prostate incision with mechanical retraction to achieve optimal clinical outcomes

Self embedding

Precisely aligned and securely anchored within the tissue to minimize the risk of migration and encrustation

Long-lasting effect

Durable, elastic implant designed to deliver sustained, long-term symptom relief

Clinical Experience

The Omega™ procedure is designed to be quick and straightforward, with a rapid recovery profile.
Patients typically experience no pain or only mild, transient discomfort that resolves within 24 hours.

Clinical Progress

The Omega device is currently under evaluation at multiple clinical sites as part of a global, multicenter clinical trial. Early interim results have exceeded expectations, demonstrating meaningful improvements in prostate symptoms compared to existing BPH treatments.